Literature DB >> 9248896

A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis.

O al-Majali1, H B Routh, O Abuloham, K R Bhowmik, M Muhsen, H Hebeheba.   

Abstract

BACKGROUND: Among the different modalities for treatment of cutaneous leishmaniasis, liquid nitrogen is considered an effective therapy with very mild side-effects.
METHODS: A study was conducted using liquid nitrogen topically for the treatment of cutaneous leishmaniasis in the King Hussain Medical Centre, Amman-Jordan. Among 468 patients of cutaneous leishmaniasis, 293 were treated with liquid nitrogen and the rest were treated with other known treatment modalities.
RESULTS: Of the patients treated with cryo surgery liquid nitrogen, 215 of 293 permitted appropriate follow-up; the clinical response was significant and effective. No systemic adverse effects were noted. Mild cutaneous complications were infrequent, and included hypopigmentation, hyperpigmentation, and scar formation.
CONCLUSIONS: From the results of this study, liquid nitrogen therapy may be considered an effective treatment for cutaneous leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9248896     DOI: 10.1046/j.1365-4362.1997.00045.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  7 in total

1.  Evaluation of the efficacy of intralesional Glucantime plus niosomal zinc sulphate in comparison with intralesional Glucantime plus cryotherapy in the treatment of acute cutaneous leishmaniasis, a randomized clinical trial.

Authors:  Saeedeh Farajzadeh; Rahim Ahmadi; Saman Mohammadi; Abbas Pardakhty; Maryam Khalili; Mahin Aflatoonian
Journal:  J Parasit Dis       Date:  2018-10-13

Review 2.  Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 3.  Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.

Authors:  Shyam Sundar; Neha Agrawal; Bhawana Singh
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-06-17       Impact factor: 4.481

4.  Comparison between intralesional injection of zinc sulfate 2 % solution and intralesional meglumine antimoniate in the treatment of acute old world dry type cutaneous leishmaniasis: a randomized double-blind clinical trial.

Authors:  Saeedeh Farajzadeh; Maryam Hakimi Parizi; Ali Akbar Haghdoost; Azadeh Mohebbi; Saman Mohammadi; Abbas Pardakhty; Sana Eybpoosh; Amireh Heshmatkhah; Behrooz Vares; Simin Saryazdi; Ali Reza Fekri; Elham Mohebbi
Journal:  J Parasit Dis       Date:  2014-11-22

Review 5.  An update on pharmacotherapy for leishmaniasis.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Expert Opin Pharmacother       Date:  2014-10-25       Impact factor: 3.889

6.  Clinical practice trends in cryosurgery: a retrospective study of cutaneous lesions.

Authors:  Fatma Sule Afsar; Ceren Dagar Erkan; Semsettin Karaca
Journal:  Postepy Dermatol Alergol       Date:  2015-03-30       Impact factor: 1.837

7.  Efficacy of cryotherapy plus topical Juniperus excelsa M. Bieb cream versus cryotherapy plus placebo in the treatment of Old World cutaneous leishmaniasis: A triple-blind randomized controlled clinical trial.

Authors:  Mohammad Mahdi Parvizi; Farhad Handjani; Mahmoodreza Moein; Gholamreza Hatam; Majid Nimrouzi; Jafar Hassanzadeh; Nasrin Hamidizadeh; Hamid Reza Khorrami; Mohammad Mehdi Zarshenas
Journal:  PLoS Negl Trop Dis       Date:  2017-10-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.